MarketCapTrends
TXG

10x Genomics Inc.

NASDAQ · Healthcare

10x Genomics Inc. annual/quarterly net income history and growth rate from 2017 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.

  • 10x Genomics Inc. net income for the quarter ending March 31, 2026 was -13.5 M, a 60.80% decrease year-over-year.
  • 10x Genomics Inc. net income for the twelve months ending March 31, 2026 was -40.8 M, a 82.01% decrease year-over-year.
  • 10x Genomics Inc. annual net income for 2025 was -43.5 M, a 76.16% decrease from 2024.
  • 10x Genomics Inc. annual net income for 2024 was -182.6 M, a 28.41% decrease from 2023.
  • 10x Genomics Inc. annual net income for 2023 was -255.1 M, a 53.67% increase from 2022.
  • 10x Genomics Inc. annual net income for 2022 was -166.0 M.
Net Income
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %